- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Vaginal Pessaries for Symptomatic Pelvic Organ Prolapse: Study Identifies Risk Factors for One-Year Failure
France: Vaginal pessaries provide effective symptom relief for pelvic organ prolapse (POP), but a recent study published in the European Journal of Obstetrics & Gynecology and Reproductive Biology found a 40% failure rate within a year, largely due to expulsion.
"Risk factors for failure included a wide genital hiatus (RR: 1.25), short total vaginal length (RR: 1.30), a high GH/TVL ratio (RR: 1.27), younger age, prior prolapse surgery (RR: 1.92), and higher pre-insertion symptom scores," the researchers reported.
Female pelvic organ prolapse (POP) is common, with severity increasing with age. Vaginal pessaries, a first-line conservative treatment, provide rapid symptom relief and improve quality of life with high satisfaction rates. Compared to surgery, pessaries are reversible and offer similar symptom improvement. Factors influencing pessary choice include POP type, symptoms, patient morphology, and handling ability. Common risk factors for failure include younger age, higher BMI, prior surgeries, short vaginal length, and advanced prolapse stages. The analysis of risk factors for pessary failure remains unclear in the literature due to variations in pessary types, patient populations, and follow-up durations across studies.
To fill this knowledge gap, A.C. Pizzoferrato, Department of Obstetrics and Gynaecology, Poitiers University Hospital, Poitiers, France, and colleagues aimed to identify the risk factors for their failure within one year of insertion.
For this purpose, the researchers prospectively included women who opted for pessary fitting to manage symptomatic pelvic organ prolapse. Symptoms and quality of life were evaluated at the time of inclusion and 1 month, 6 months, and 1 year post-insertion using validated questionnaires, including PFDI-20, ICIQ-SF, PISQ-12, USP, and PFIQ-7. Patient satisfaction was measured using the PGII score, and pessary failure was defined as discontinuation of use during the study period.
The following were the key findings of the study:
- Of the 206 women included, 175 had results available at 1 year.
- At 1 year, 70 women (40.0%) experienced pessary failure, while 105 women (60.0%) continued using the pessary.
- The overall PFDI-20 symptom score and its subscores showed significant improvement as early as 1 month after pessary insertion.
- Risk factors for pessary failure included:
- Younger age at insertion (RR per 5-year increase = 0.93).
- History of prolapse surgery (RR = 1.92).
- Higher PFDI-20 score before insertion (RR = 1.04).
- Wide genital hiatus (GH) (RR = 1.25).
- Short total vaginal length (TVL) (RR = 1.30).
- High GH/TVL ratio (RR = 1.27).
- Presence of a POP-Q stage ≥2 rectocele (RR = 1.51).
- At 1 year, 89.9% of users reported feeling improved or very improved.
- 85.7% expressed intent to continue pessary use for 5 years or longer.
The researchers concluded that the study highlights the vaginal pessary as an effective treatment for symptomatic pelvic organ prolapse, significantly improving patients' quality of life. However, factors like a wide genital hiatus or short vaginal length are associated with higher expulsion rates and increased risk of failure. Despite these challenges, user satisfaction remains high, with most women reporting positive outcomes in one year.
Reference: Pizzoferrato, A., Deparis, J., Levade, C., Villot, A., & Fauvet, R. (2024). Use of vaginal pessary in women with symptomatic pelvic organ prolapse: Risk factors for failure one year after insertion. European Journal of Obstetrics & Gynecology and Reproductive Biology. https://doi.org/10.1016/j.ejogrb.2024.12.054
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751